Stockscreener 앱 받기
5.68
0.70%
-0.04
시간 외 거래:
5.68
전일 마감가:
$5.72
열려 있는:
$5.76
하루 거래량:
983.09K
Relative Volume:
0.48
시가총액:
$2.12B
수익:
$10.27B
순이익/손실:
$120.00M
주가수익비율:
13.71
EPS:
0.4142
순현금흐름:
$949.99M
1주 성능:
+7.98%
1개월 성능:
+14.52%
6개월 성능:
-7.04%
1년 성능:
+30.88%
1일 변동 폭
$5.68
$5.85
1주일 범위
$5.225
$5.85
52주 변동 폭
$4.28
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
5.68 | 2.09B | 10.27B | 120.00M | 949.99M | 0.4142 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Companies Inc. and Ortho Dermatologics Announces Launch Of Biafine Skin Recovery Emulsion Through Convenient Online Ordering - marketscreener.com
Bausch Health rises after $300M worth insider purchase (update) - MSN
Bausch Health launches Biafine skincare emulsion online in U.S. By Investing.com - Investing.com Canada
French skin cream sold since 1971 is now available online in the U.S. - Stock Titan
Patterns Watch: Can Bausch Health Companies Inc expand into new markets - baoquankhu1.vn
What makes Bausch Health (BHC) appear so attractive - MSN
Market Wrap: Is Bausch Health Companies Inc subject to activist investor interestWeekly Trend Summary & Precise Swing Trade Alerts - baoquankhu1.vn
Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand - GlobeNewswire Inc.
Forecast Cut: Will Bausch Health Companies Inc announce a stock splitWeekly Market Outlook & Real-Time Market Sentiment Reports - baoquankhu1.vn
Earnings Update: How does Bausch Health Companies Inc perform in inflationary periods2026 Snapshot & Low Risk High Win Rate Picks - baoquankhu1.vn
US Market Recap: Is Bausch Health Companies Inc likely to announce a buybackQuarterly Profit Review & Accurate Entry/Exit Alerts - baoquankhu1.vn
Analyst Downgrade: Whats the outlook for Bausch Health Companies Incs sectorBreakout Watch & Weekly Top Gainers Trade List - baoquankhu1.vn
Global Keloid Treatment Market Outlook | North America, Asia Pacific, Europe Lead | Bausch Health, Sciton, Galderma Drive Multi-Modal Dermatology Innovation - Morningstar
Street Watch: Is Bausch Health Companies Inc subject to activist investor interest2026 Sentiment & Stock Portfolio Risk Control - baoquankhu1.vn
Bausch Health Releases Additional Proxy Materials - National Today
[ARS] Bausch Health Companies Inc. SEC Filing - Stock Titan
Bausch Health (NYSE: BHC) outlines 2026 virtual meeting, board slate and say-on-pay vote - Stock Titan
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update – Company AnnouncementFT.com - Financial Times
Bausch Health Companies Inc. (BHC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Treasury Yields: Does Bausch Health Companies Inc have a sustainable dividend2026 Price Swings & Weekly Market Pulse Alerts - baoquankhu1.vn
Bausch reaches deal with competitor over IBS drug generic - Life Sciences Intellectual Property Review
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe - Financial Times
Bausch Health Companies (TSE:BHC) Trading Up 0.3%Should You Buy? - MarketBeat
Bausch, MSN Laboratories Settle Patent Battle Over IBS Drug - Law360
Aug Movers: Can Bausch Health Companies Inc beat the S P 5002026 Pullbacks & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Bausch Health (NYSE: BHC) director receives 5,946 RSUs for board service - Stock Titan
John Paulson receives 11,574 Bausch Health (NYSE: BHC) RSUs as fees - Stock Titan
[Form 4] Bausch Health Companies Inc. Insider Trading Activity - Stock Titan
Bausch Health Companies Inc. (BHC.TO) stock price, news, quote and history - Yahoo Finance UK
Bausch Health to Announce First Quarter 2026 Results on April 29 - GuruFocus
List of 22 Acquisitions by Bausch Health (Apr 2026) - Tracxn
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Eastern Progress
What Makes Bausch Health (BHC) Appear So Attractive - Insider Monkey
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 - Bitget
Bausch Health (BHC) Climbs 45% on Insider Buying - MSN
Nasdaq Moves: Can Bausch Health Companies Inc beat the S P 500Trade Analysis Summary & Community Verified Trade Signals - baoquankhu1.vn
Trend Report: What is Bausch Health Companies Incs valuation compared to sectorQuarterly Profit Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program - Bioscience Association Manitoba
Death Cross: Can Bausch Health Companies Inc beat the S P 5002026 Growth vs Value & Real-Time Buy Signal Notifications - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Bausch Health Cos Inc. (NYSE:BHC) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER S - GuruFocus
Analysts Are Optimistic We'll See A Profit From Bausch Health Companies Inc. (NYSE:BHC) - 富途牛牛
Six students with skin conditions can get up to $10,000 each - Stock Titan
Bausch Health unit moves to settle charges it misled investors -SEC - AOL.com
Death Cross: Is Bausch Health Companies Inc impacted by rising ratesEarnings Recap Report & Technical Buy Zone Confirmations - baoquankhu1.vn
Is the Options Market Signaling a Surge for Bausch Health Shares? - Bitget
Is the Options Market Predicting a Spike in Bausch Health Stock? - Zacks Investment Research
EPS Watch: Is Bausch Health Companies Inc subject to activist investor interest2026 Price Momentum & Verified High Yield Trade Plans - baoquankhu1.vn
If You Invested $1,000 in Bausch Health Companies Inc (BHC) - Stock Titan
Published on: 2026-03-21 08:43:51 - baoquankhu1.vn
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
1.05%
자본화:
|
볼륨(24시간):